Moreover, IL-2, encoding IL-2, expression was associated with FoxP3 in The Cancer Genome Atlas HNSCC cohort (Fig. S5A), which not only diminishes its immune activation effects but also increases suppressive populations, thereby reducing its overall efficacy. This evidence concerns the gene FOXP3 and head and neck squamous cell carcinoma.